No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs3789439 |
chr1:94579426-94579427 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs139699862 |
chr1:94579448-94579449 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs185601748 |
chr1:94579482-94579483 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs576195661 |
chr1:94579490-94579491 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs545266674 |
chr1:94579491-94579492 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs371308038 |
chr1:94579534-94579535 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs533950783 |
chr1:94579565-94579566 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs375511778 |
chr1:94579597-94579598 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs558600933 |
chr1:94579598-94579599 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs572372199 |
chr1:94579628-94579629 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs74963419 |
chr1:94579629-94579630 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs530123333 |
chr1:94579666-94579667 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs3789440 |
chr1:94579672-94579673 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
14 |
rs563884047 |
chr1:94579767-94579768 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs4847197 |
chr1:94579829-94579830 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs143362625 |
chr1:94579837-94579838 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs372154507 |
chr1:94579874-94579875 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs566250805 |
chr1:94579900-94579901 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs190097110 |
chr1:94579902-94579903 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs547414908 |
chr1:94579975-94579976 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs567312796 |
chr1:94579990-94579991 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs528198887 |
chr1:94579992-94579993 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs376544473 |
chr1:94579996-94579997 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs11419879 |
chr1:94580044-94580045 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs11583439 |
chr1:94580055-94580056 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs12025221 |
chr1:94580059-94580060 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs11805421 |
chr1:94580065-94580066 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs373919359 |
chr1:94580091-94580092 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs569804448 |
chr1:94580125-94580126 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs538470982 |
chr1:94580143-94580144 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs558776094 |
chr1:94580168-94580169 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs550047521 |
chr1:94580174-94580175 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs572254752 |
chr1:94580204-94580205 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs373184324 |
chr1:94580210-94580211 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs12035820 |
chr1:94580233-94580234 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs532323956 |
chr1:94580247-94580248 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs552549143 |
chr1:94580285-94580286 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs181797841 |
chr1:94580332-94580333 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs543483171 |
chr1:94580335-94580336 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs563644583 |
chr1:94580411-94580412 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs532696413 |
chr1:94580444-94580445 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs546081307 |
chr1:94580451-94580452 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs559941103 |
chr1:94580549-94580550 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs117829737 |
chr1:94580625-94580626 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs548935656 |
chr1:94580680-94580681 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs565977150 |
chr1:94580700-94580701 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs560848477 |
chr1:94580720-94580721 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs529738923 |
chr1:94580775-94580776 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs549814069 |
chr1:94580813-94580814 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs137895434 |
chr1:94580825-94580826 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|